Coya Therapeutics, Inc. (COYA)
NASDAQ·Healthcare·Biotechnology
$4.79
+3.23%
Mkt Cap $80.42M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$17.50
Range $17.00 – $18.00
Implied Upside
+265.3%
Consensus $17.50 vs current $4.79
NASDAQ·Healthcare·Biotechnology
$4.79
+3.23%
Mkt Cap $80.42M
No recent rating data.
Price Target (2 analysts)
$17.50
Range $17.00 – $18.00
+265.3%
Consensus $17.50 vs current $4.79